Levalbuterol Tartrate Hfa Inhalation Aerosol, Metered
Product Images NDC 63187-876
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levalbuterol Tartrate Hfa Inhalation (NDC 63187-876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Levalbuterol Tartrate Hfa Inhalation 2)
Figure 1 (Levalbuterol Tartrate Hfa Inhalation 3)
Figure 1 (Levalbuterol Tartrate Hfa Inhalation 4)
Figure 2 (Levalbuterol Tartrate Hfa Inhalation 5)
Figure 3 (Levalbuterol Tartrate Hfa Inhalation 6)
Figure 4 (Levalbuterol Tartrate Hfa Inhalation 7)
Figure 5 (Levalbuterol Tartrate Hfa Inhalation 8)
63187-876-15 (Levalbuterol Tartrate Hfa Inhalation 9)
Levalbuterol Tartrate HFA 45mcg inhaler is a prescription drug distributed by Actavis Pharma, Inc. It contains 15g inhaler with each actuation delivering a suspension of 59 mcg of micronized levalbuterol tartrate equivalent to 45mcg levalbuterol. It is recommended to keep the medication out of the reach of children and store it at 20°-25°C (68°-77°F). The package insert should be referred to for more information. The inhaler has a lot number, Product ID: RLO87615, and SN# MASTER. There are three NDCs: 63187-876-15, 83187-876-15, and 63187-876-15, and all have the same lot number and expiry date. The inhaler has been relabeled by Proficient Rx LP in Thousand Oaks, CA 91320.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.